|
End-of-day quote
Other stock markets
|
||
| - INR | - |
|
| 16-03-07 | UCB : Pharma crusader takes India's drug regulators to court | RE |
| 15-06-28 | Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +1.89% | +3.20% | -0.68% | +20.76% | +10.91% | +59.70% | +165.18% | +352.45% | +1,361.43% | 1,043B | |
| -0.24% | +0.45% | -0.91% | +14.41% | +24.17% | +50.64% | +52.02% | +48.45% | +106.84% | 621B | |
| -0.95% | -5.26% | -4.27% | +18.94% | +6.73% | +24.23% | +65.08% | +113.08% | +266.50% | 435B | |
| 0.00% | +3.20% | +9.92% | +13.30% | +11.12% | +46.70% | +37.60% | +3.24% | +45.71% | 361B | |
| +0.58% | -1.26% | +0.06% | +8.25% | +14.22% | +35.52% | +40.54% | +49.92% | +53.50% | 293B | |
| -1.55% | -6.84% | -15.96% | -12.65% | -14.07% | +7.20% | +8.62% | +45.27% | +127.01% | 251B | |
| -0.73% | +4.44% | +10.48% | +22.27% | +23.69% | +42.22% | +66.41% | +75.91% | +133.13% | 220B | |
| -0.24% | -11.27% | -8.56% | +0.20% | -9.73% | +1.42% | -44.69% | -6.33% | +77.94% | 201B | |
| -0.68% | -0.32% | +0.96% | -3.99% | +6.62% | +18.66% | +66.32% | +90.26% | +62.74% | 164B | |
| +1.51% | +5.18% | +10.46% | -1.24% | +5.22% | +9.49% | -25.19% | -41.87% | -26.07% | 147B | |
| +0.82% | -1.09% | +13.14% | +13.36% | +18.93% | +43.13% | +6.05% | -5.83% | +1.37% | 130B | |
| -0.17% | +0.48% | -8.60% | +13.18% | +6.77% | +25.51% | +42.16% | +141.21% | +372.55% | 123B | |
| +1.10% | -0.18% | -2.34% | +3.28% | +6.14% | +41.04% | +43.76% | +7.85% | -8.57% | 103B | |
| -0.26% | +2.12% | -0.27% | -0.44% | -10.17% | -6.73% | -20.88% | -13.84% | +2.45% | 103B | |
| +0.90% | -1.54% | -10.43% | -15.69% | -17.20% | -7.77% | +63.39% | +67.44% | +467.17% | 69.83B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +0.37% | +1.98% | -3.48% | +28.28% | +33.48% | +97.80% | -4.30% | +5.06% | -48.47% | 55.83B | |
| +1.57% | -0.13% | +1.06% | +3.69% | +13.88% | +30.17% | +25.91% | +51.97% | +17.30% | 53.39B | |
| -2.67% | -3.30% | -4.30% | -3.29% | -12.52% | -16.36% | +26.88% | -6.61% | +220.35% | 52.37B | |
| Average | -0.10% | -1.85% | -0.76% | +6.81% | +6.57% | +27.92% | +34.16% | +54.31% | +179.60% | 224.53B | |
| Weighted average by Cap. | -0.35% | -1.22% | -0.45% | +11.55% | +9.65% | +37.34% | +65.20% | +117.82% | +407.90% |
- Stock Market
- Stocks
- RANB Stock
- Sector Ranbaxy Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
